Bold truth: aging faster may be shaping the risk you already worry about with high uric acid, gout, and diet. In a large, forward-looking study, researchers tracked 412,493 UK Biobank participants to uncover how biological aging interacts with serum uric acid, hyperuricemia, and gout risk. Using several regression models, they found that each incremental step of accelerated biological aging is tied to an average rise of 8.1 μmol/L in serum uric acid, with strong statistical support and tight confidence intervals.
Compared with peers whose biological aging progressed at a slower pace, those with accelerated aging had about 40% higher odds of developing hyperuricemia and roughly 39% higher odds of gout. Among individuals already experiencing hyperuricemia, faster aging added another roughly 14% increased risk of advancing to gout. This suggests that biological aging may act as a modifier of disease progression, not merely a background feature.
To probe causality beyond observation, the researchers conducted Mendelian randomization analyses. Genetic indicators of slower biological aging were associated with a lower gout risk, supporting a potential causal pathway: slower aging could help reduce gout risk and modify how hyperuricemia develops into gout. These genetic results align with the cohort findings, indicating that aging biology may influence gout outcomes.
The study also considered dietary signals linked to anti-aging effects. They used a composite dietary antioxidant index as a proxy for antioxidant-rich eating patterns. Among hyperuricemic participants, those with a positive antioxidant index showed a 68% reduction in the odds of developing gout compared with those with a negative index. Although the statistical signal was borderline, this pattern hints that antioxidant-dense diets might contribute to healthier aging and help prevent gout in people with elevated uric acid.
Clinical implications point toward treating aging as a new risk dimension alongside classic metabolic factors. For clinicians managing hyperuricemia and gout, measuring biological aging markers could help stratify who is most at risk. The findings also support promoting healthy aging strategies, especially antioxidant-rich dietary patterns, as a complementary approach to urate-lowering therapy when aiming to prevent progression from hyperuricemia to gout.
Reference: Li N et al. Biological aging and gout risk in hyperuricemia: a UK biobank cohort study. Int J Surg. 2025; doi:10.1097/JS9.0000000000003948.
Author:
Each article is available under the Creative Commons Attribution-Non Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/).
